deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT01602198

Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients

24-week, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Exelon® [Rivastigmine] Transdermal Patch in 120 APOE e4 Positive Amnestic MCI Patients

Sponsor: The Cleveland Clinic

Conditions Mild Cognitive Disorder Mild Cognitive Impairment
Interventions Exelon [rivastigmine] transdermal patch Placebo transdermal patch
Updated 9 times since 2017 Last updated: Jan 9, 2017 Started: Jun 30, 2011 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study revised to use a different study medication and patient population.

Other terminated trials from The Cleveland Clinic

See all terminations from The Cleveland Clinic

This NA trial investigates Mild Cognitive Disorder and Mild Cognitive Impairment and is currently terminated or withdrawn. The Cleveland Clinic leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~May 2017 · 3 months · monthly snapshotTerminated~May 2017 – ~Jun 2018 · 13 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated NA

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated NA

  5. Jan 2021 — Dec 2022 [monthly]

    Terminated NA

▶ Show 4 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

  2. May 2017 — Jun 2018 [monthly]

    Terminated NA

  3. Feb 2017 — May 2017 [monthly]

    Terminated NA

  4. Jan 2017 — Feb 2017 [monthly]

    Terminated NA

    First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The Cleveland Clinic
Data source: The Cleveland Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations